Acute leukaemia, Acute myeloid leukaemia (AML), Blood cancers, Leukaemia, Myelodysplastic syndrome (MDS)
Open
Other
This study is assessing the value of prehabilitation for people with acute myeloid leukaemia and myelodysplastic syndrome.
It is open to people who have:
acute myeloid leukaemia (AML) with no sign of their leukaemia after initial (induction) chemotherapy
AML that has come back and after further treatment there is no sign of their leukaemia
myelodysplastic syndrome (MDS) that has excess blast cells
Recruitment start: 29 September 2023
Recruitment end: 30 September 2025
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Janet Dunn Professor Simon Stanworth
NIHR Evaluation Trials and Studies Coordinating Centre (NETSCC)
National Institute of Health and Research: Health Technology Assessment programme
University of Warwick
University Hospitals Coventry and Warwickshire
Last reviewed: 27 Feb 2025
CRUK internal database number: 19382
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
